Your browser doesn't support javascript.
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.
Abu-Raddad, Laith J; Chemaitelly, Hiam; Ayoub, Houssein H; Tang, Patrick; Coyle, Peter; Hasan, Mohammad R; Yassine, Hadi M; Benslimane, Fatiha M; Al-Khatib, Hebah A; Al-Kanaani, Zaina; Al-Kuwari, Einas; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Abdul-Rahim, Hanan F; Nasrallah, Gheyath K; Al-Kuwari, Mohamed Ghaith; Butt, Adeel A; Al-Romaihi, Hamad Eid; Al-Khal, Abdullatif; Al-Thani, Mohametabd H; Bertollini, Roberto.
  • Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. lja2002@qatar-med.cornell.edu.
  • Chemaitelly H; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar. lja2002@qatar-med.cornell.edu.
  • Ayoub HH; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. lja2002@qatar-med.cornell.edu.
  • Tang P; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. lja2002@qatar-med.cornell.edu.
  • Coyle P; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Hasan MR; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
  • Yassine HM; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Benslimane FM; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Al-Khatib HA; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Al-Kanaani Z; Hamad Medical Corporation, Doha, Qatar.
  • Al-Kuwari E; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Jeremijenko A; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.
  • Kaleeckal AH; Department of Pathology, Sidra Medicine, Doha, Qatar.
  • Latif AN; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Shaik RM; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Abdul-Rahim HF; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Nasrallah GK; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Al-Kuwari MG; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Butt AA; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
  • Al-Romaihi HE; Hamad Medical Corporation, Doha, Qatar.
  • Al-Khal A; Hamad Medical Corporation, Doha, Qatar.
  • Al-Thani MH; Hamad Medical Corporation, Doha, Qatar.
  • Bertollini R; Hamad Medical Corporation, Doha, Qatar.
Nat Commun ; 13(1): 532, 2022 01 27.
Article in English | MEDLINE | ID: covidwho-1655582
ABSTRACT
SARS-CoV-2 breakthrough infections in vaccinated individuals and in those who had a prior infection have been observed globally, but the transmission potential of these infections is unknown. The RT-qPCR cycle threshold (Ct) value is inversely correlated with viral load and culturable virus. Here, we investigate differences in RT-qPCR Ct values across Qatar's national cohorts of primary infections, reinfections, BNT162b2 (Pfizer-BioNTech) breakthrough infections, and mRNA-1273 (Moderna) breakthrough infections. Our matched-cohort analyses of the randomly diagnosed infections show higher mean Ct value in all cohorts of breakthrough infections compared to the cohort of primary infections in unvaccinated individuals. The Ct value is 1.3 (95% CI 0.9-1.8) cycles higher for BNT162b2 breakthrough infections, 3.2 (95% CI 1.9-4.5) cycles higher for mRNA-1273 breakthrough infections, and 4.0 (95% CI 3.5-4.5) cycles higher for reinfections in unvaccinated individuals. Since Ct value correlates inversely with SARS-CoV-2 infectiousness, these differences imply that vaccine breakthrough infections and reinfections are less infectious than primary infections in unvaccinated individuals. Public health benefits of vaccination may have been underestimated, as COVID-19 vaccines not only protect against acquisition of infection, but also appear to protect against transmission of infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-28199-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-28199-7